Letters Drug pricing

PPRS is not NICE

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39339.451262.3A (Published 20 September 2007) Cite this as: BMJ 2007;335:578
  1. Andrea Messori, coordinator
  1. Laboratory of Pharmacoeconomics, Azienda Careggi, 50134 Florence, Italy
  1. andreamessori{at}interfree.it

Some of Burnand's comments on Iheanacho's article are astonishing.1 If the mission of any national health system is maximising health, this mission is pursued by assuming that spending on a drug buys not the milligrams of the active substance but the clinical …

View Full Text

Log in

Log in through your institution


* For online subscription